DUBLIN--(BUSINESS WIRE)--Sep 13, 2018--The "Epinephrine 2017 U.S. Promotional Audit Report" report has been added to ResearchAndMarkets.com's offering.

The 5 Key Questions Addressed by this Report:

How many physicians were reached by Epinephrine through reportable promotional activity in 2017 and how does this compare to its peer set in the Anaphylaxis market? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity? How does Mylan's depth of coverage vary within key specialties (e.g., Pediatric Medicine, Family Medicine, Allergy/Immunology, Otolaryngology, Internal Medicine, and Pulmonology) and how does this compare to its peers and the overall set of rep-accessible physicians? How often are physicians receiving paid meals for Epinephrine throughout the year (e.g., monthly, quarterly, annually)? Who were the most frequent meal recipients and top paid speakers for Epinephrine in 2017?

Data Sources and Methodology:

The author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. More than four years of longitudinal data is available - covering payments to more than 975,000 U.S. healthcare professionals. Over 10,300 paid interactions across 6,700 physicians made on behalf of Epinephrine were carefully examined to support our analysis. For more information about this report visit https://www.researchandmarkets.com/research/6b4krj/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180913005381/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Asthma Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/13/2018 04:52 AM/DISC: 09/13/2018 04:51 AM

http://www.businesswire.com/news/home/20180913005381/en